{"transactions":[{"id":1731598,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":108009,"kind":"person","name":"Trujillo Carlos","position":1,"cik":"0001464520","reported_name":"Trujillo Carlos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:45.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 50% on November 20, 2023 and 50% on November 20, 2024."}],"balance_after":85000,"derivative":{"exercise_price":2.18,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-23-008432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008432/ownership.xml","form_type":"4"}}]}